Latest Medical Technology News

Page 1 of 23
CurveBeam AI has received its first Chinese order for four HiRise weight-bearing CT systems from Weiying/Wego Orthopedics, turning regulatory clearance into an initial commercial foothold. The order value and delivery schedule were not disclosed, while a further A$1 million milestone investment is expected this quarter.
Victor Sage
Victor Sage
19 Nov 2026
Imricor Medical Systems (ASX:IMR) has moved from regulatory preparation into US commercial deployment, signing its first two NorthStar hospital customers within weeks of launch. The milestone comes with sharply higher quarterly revenue, a fresh Philips pathway and a still-heavy cash burn.
Victor Sage
Victor Sage
13 Nov 2026
Artrya has signed its first inbound US customer outside its foundation and research relationships, securing a five-year HonorHealth agreement with a minimum value of US$0.5 million. The Salix platform will be deployed across the Arizona health system’s nine-hospital CCTA network.
Victor Sage
Victor Sage
13 Nov 2026
AVITA Medical has raised its 2026 revenue guidance for a second time after third-quarter revenue climbed 53% year on year. The company also drew a further US$10 million under its credit facility and removed its going-concern qualification, although it remains loss-making and highly leveraged.
Victor Sage
Victor Sage
6 Nov 2026
BD finished fiscal 2026 with higher revenue, adjusted earnings and cash generation, while setting low single-digit growth expectations for the year ahead. Its proposed US$19 billion US investment adds scale to the strategy, but remains tied to milestones and future implementation.
Ada Torres
Ada Torres
5 Nov 2026
4DMedical has denied holding undisclosed information that could explain a sharp sell-off in its shares, after ASX queried a fall from $3.28 to $2.41. The company said it believes increased short interest was responsible and confirmed compliance with continuous disclosure rules.
Victor Sage
Victor Sage
2 Nov 2026
Orthocell has recorded its strongest month of US Remplir sales since launch, with 92 units generating A$279,000 in October. The result points to improving surgeon adoption and hospital access, although one month of sales does not yet establish a durable run rate or profitability.
Victor Sage
Victor Sage
2 Nov 2026
Visionflex ended the September quarter with A$657,000 in cash and estimated funding for just 2.1 quarters, while aged care subscription losses drove a 25% fall in reported ARR. Revenue edged higher and costs improved, but the company now needs hardware wins to become recurring income before liquidity tightens further.
Victor Sage
Victor Sage
30 Oct 2026
Micro-X has reported a sharp improvement in Rover order activity and more than $3 million in annualised cost savings, while redirecting its strategy towards medical CT. The September quarter still consumed $4.4 million in operating cash, leaving funding dependent on further note proceeds, an expected tax refund and milestone receipts.
Victor Sage
Victor Sage
30 Oct 2026
Ceretas has enrolled the first patient in its Phase 2 CERE-CALM Alzheimer’s trial after completing its first quarter as an ASX-listed company. The medical technology group ended September with $7.1 million in cash, while a device milestone unlocked a further $692,578 in non-dilutive funding.
Victor Sage
Victor Sage
30 Oct 2026
OncoSil Medical enters FY27 with FDA approval for its cancer device, rising quarterly revenue and fresh institutional funding, but its U.S. opportunity still depends on reimbursement and a tightly controlled initial rollout. Cash rose to A$8.7 million after the capital raise, while operating cash use remained substantial.
Victor Sage
Victor Sage
30 Oct 2026
Optiscan has moved its InForm and InVue medical-imaging devices into formal US FDA review after a quarter of intensive regulatory and clinical work. The milestone comes with $11.093 million in cash and a reported 3.5 quarters of funding at the latest operating burn rate.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive